These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34387145)

  • 1. Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality.
    Mitrovic M; Pantic N; Sabljic N; Vucic M; Bukumiric Z; Virijevic M; Pravdic Z; Rajic J; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
    Leuk Lymphoma; 2021 Dec; 62(14):3516-3520. PubMed ID: 34387145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Care of the Leukemic Patients in Times of SARS-CoV-2.
    Karki NR; Le T; Cortes J
    Curr Oncol Rep; 2021 Aug; 23(10):114. PubMed ID: 34342734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score.
    Obremska M; Pazgan-Simon M; Budrewicz K; Bilaszewski L; Wizowska J; Jagielski D; Jankowska-Polanska B; Nadolny K; Madowicz J; Zuwala-Jagiello J; Zysko D; Banasiak W; Simon K
    BMC Infect Dis; 2021 Sep; 21(1):945. PubMed ID: 34521357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
    Palanques-Pastor T; Megías-Vericat JE; Martínez P; López Lorenzo JL; Cornago Navascués J; Rodriguez Macias G; Cano I; Arnan Sangerman M; Vidriales Vicente MB; Algarra Algarra JL; Foncillas MÁ; Herrera P; Botella Prieto C; Vives S; Figuera Álvarez Á; Cuevas Palomares L; Sobas M; Contento Gonzalo A; Cuello García R; Amutio Diez ME; De Miguel Llorente D; Navas Elorza B; Bergua Burgues JM; Bernal Del Castillo T; Mateos Rodríguez MC; de Cabo López E; Franco Villegas AC; García Boyero R; Escolano Escobar C; Seri Merino C; Cervero C; Roldán Pérez A; Hermosín Ramos L; Cervera Calvo M; Olave MT; Villafuerte Gutiérrez P; de Laiglesiai A; Serrano J; Najera Irazu MJ; Piñana JL; Sanz MÁ; Martínez-López J; Montesinos P
    Leuk Lymphoma; 2021 Dec; 62(12):2928-2938. PubMed ID: 34292118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
    Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
    Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
    Lampasona V; Secchi M; Scavini M; Bazzigaluppi E; Brigatti C; Marzinotto I; Davalli A; Caretto A; Laurenzi A; Martinenghi S; Molinari C; Vitali G; Di Filippo L; Mercalli A; Melzi R; Tresoldi C; Rovere-Querini P; Landoni G; Ciceri F; Bosi E; Piemonti L
    Diabetologia; 2020 Dec; 63(12):2548-2558. PubMed ID: 33029657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
    Cattaneo C; Daffini R; Pagani C; Salvetti M; Mancini V; Borlenghi E; D'Adda M; Oberti M; Paini A; De Ciuceis C; Barbullushi K; Cancelli V; Belotti A; Re A; Motta M; Peli A; Bianchetti N; Anastasia A; Dalceggio D; Roccaro AM; Tucci A; Cairoli R; Muiesan ML; Rossi G
    Cancer; 2020 Dec; 126(23):5069-5076. PubMed ID: 32910456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
    Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
    J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review.
    Huntley BJF; Huntley ES; Di Mascio D; Chen T; Berghella V; Chauhan SP
    Obstet Gynecol; 2020 Aug; 136(2):303-312. PubMed ID: 32516273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19.
    Barbero P; Mugüerza L; Herraiz I; García Burguillo A; San Juan R; Forcén L; Mejía I; Batllori E; Montañez MD; Vallejo P; Villar O; García Alcazar D; Galindo A
    J Matern Fetal Neonatal Med; 2022 Jul; 35(14):2648-2654. PubMed ID: 32689846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contamination of SARS-CoV-2 in patient surroundings and on personal protective equipment in a non-ICU isolation ward for COVID-19 patients with prolonged PCR positive status.
    Wei L; Huang W; Lu X; Wang Y; Cheng L; Deng R; Long H; Zong Z
    Antimicrob Resist Infect Control; 2020 Oct; 9(1):167. PubMed ID: 33121538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
    Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
    Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.